DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Farber disease
Farber disease
Sphingolipid Metabolism Diseases ⁎ Thomas Kolter, Konrad Sandhoff
Genetic Ablation of Acid Ceramidase in Krabbe Disease Confirms the Psychosine Hypothesis and Identifies a New Therapeutic Target
The Multiple Roles of Sphingomyelin in Parkinson's Disease
Farber Lipogranulomatosis
HHS Public Access Author Manuscript
Soonerstart Automatic Qualifying Syndromes and Conditions
Diagnosis of Metachromatic Leukodystrophy, Krabbe Disease, and Farber Disease After Uptake of Fatty Acid-Labeled Cerebroside Sulfate Into Cultured Skin Fibroblasts
Consensus Recommendation for a Diagnostic Guideline for Acid Sphingomyelinase Deficiency
Disorders of Sphingolipid Synthesis, Sphingolipidoses, Niemann-Pick Disease Type C and Neuronal Ceroid Lipofuscinoses
Acid Ceramidase Deficiency: Farber Disease and SMA-PME Fabian P
Case Report Farber Disease Misdiagnosed As
Retrovirus-Mediated Gene Therapy for Farber Disease
A Cross-Sectional Quantitative Analysis of the Natural History of Farber
Farber's Disease: a Case Report
The Origins of Glucosylsphingosine in Gaucher Disease John J
Lipid Storage Diseases
Synaptic Dysfunction As a Starting Point for Disease Progression
Acid Sphingomyelinase Deficiency Ameliorates Farber Disease
Top View
Abnormal Sphingolipid World in Inflammation Specific for Lysosomal
Farber Disease
Clinical Diagnosis of Farber's Disease- a Rare Case Report
Lysosomal Storage Diseases ª the Author(S) 2014 DOI: 10.1177/2326409813517663 Iem.Sagepub.Com
Farber Disease: a Rare Neurodegenerative Disorder Ameer Ahmad1, Atta Ullah Mazhar1 and Muhammad Anwar2
Lipid Storage Diseases
Acid Ceramidase Deficiency in Mice Results in a Broad Range Of
Pathological Manifestations of Farber Disease in a New Mouse Model
38 Disorders of Sphingolipid Metabolism
Niemann - Pick Disease Type B: a Case Report AFSANA YASMIN1, MD
C26-Ceramide As Highly Sensitive Biomarker for the Diagnosis Of
Niemann-Pick Disease Type A-A Case Report
Annual Report 2005-2006
Home Care Manual
Lysosomal Lipid Storage Diseases
Farber Disease: a Fatal Childhood Disorder with Nervous System
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Sphingolipidoses
Clinical Characteristics of 248 Patients with Krabbe Disease: Quantitative Natural History Modeling Based on Published Cases
Soonerstart Automatic Qualifying Syndromes and Conditions
Prevalence of Lysosomal Storage Disorders
Lysosomal Storage Diseases Carlos Ferreira George Washington University
Lysosomal Storage Diseases
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: a Review
Genetic Ablation of Acid Ceramidase in Krabbe Disease Confirms the Psychosine Hypothesis and Identifies a New Therapeutic Target
Farber Disease: Understanding a Fatal Childhood Disorder and Dissecting Ceramide Biology Mark S
(I-Cell Disease): Ultrastructural Observations of Conjunctiva and Skin